Sun Pharma
Mark Hagler currently serves as Chief Commercial Officer at SUN PHARMA, overseeing a $1 billion business with full P&L responsibility and leading a team of over 600 in commercial operations and sales. Mark has extensive experience in the pharmaceutical industry, having held key positions at various companies including Board Member at SLAM BioTherapeutics and former Board Member at Ranbaxy Signature JV. Prior roles include Head of Oncology Marketing at Ipsen, Vice President of Business Development at Axess Oncology, and US Commercial Brand Leader at Sanofi. Educational credentials include an MBA in Finance from The Johns Hopkins University and a Bachelor of Science in Engineering from the United States Naval Academy.
This person is not in any teams
This person is not in any offices
Sun Pharma
26 followers
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe and a multi-cultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 2,000 scientists and R&D investments of over 7-8% of annual revenues. See our community guideline: bit.ly/3DsQxdK